Urea can crystallise with other compounds. These can be called urea adducts or if a solvent is involved, a urea solvate, and the process is called urea extraction crystallization. Urea can also be a neutral ligand if it is coordinated to a central metal atom. Urea can form hydrogen bonds to other oxygen and nitrogen atoms in the substance it crystallises with. This stiffens the solid and raises the melting point. [1] T
name | formula | ratio urea: solute | crystal system | space group | unit cell | volume | density | comment | reference |
---|---|---|---|---|---|---|---|---|---|
hydrogen peroxide; urea (1:1) | HOOH•CH4N2O | 1:1 | orthorhombic | Pnca | a 6.732 b 4.8207 c 12.873 Z=4 | decomposes slowly at room temperature | [2] | ||
urea; acetic acid (1:2) | 2CH3COOH•CH4N2O | 1:2 | monoclinic | P21/n | a 7.6549 b 10.1351 c 11.5219 β 99.570° Z=4 | 881.47 | 1.358 | unstable in air | [3] |
oxalic acid; urea (1:1) | C2H2O4•CH4N2O | 1:1 | monoclinic | C2/c | a 13.0625 b 6.6437 c 6.8478 β 92.474° | [4] | |||
oxalic acid; urea (1:2) | C2H2O4•2CH4N2O | 2:1 | monoclinic | P2/c | a 5.058 b 12.400 c 6.964 β 98.13° | [5] | |||
Urea - N,N-dimethylformamide (3:1) | 3CH4N2O·C3H7NO | 3:1 | triclinic | P1 | a = 7.525 b = 9.866 c = 10.821 α = 65.61° β = 79.43° γ = 70.76° Z=2 | 689.7 | 1.219 | colourless @150K | [6] |
N,N-dimethylacetamide; urea (1:1) | C4H9NO·CH4N2O | 1:1 | monoclinic | C2/c | a = 7.2770 b = 17.5394 c = 7.3789 β = 119.450° Z=4 | 820.11 | 1.192 | colourless @120K | [7] |
Urea malonic acid | 1:1 | monoclinic | P2/c | a 13.091 b 5.455 c 9.933 β 104.39° | [8] | ||||
Maleic acid; urea (1:1) | 1:1 | monoclinic | Cc | a 5.144 b 9.999 c 14.80 β 95.1° | [9] | ||||
Succinic acid bis urea | 2:1 | monoclinic | P21/c | a 5.637 b 8.243 c 12.262 β 96.75° Z=2 | 565.81 | 1.41 | [10] | ||
Maleic acid; urea (2:1) | 2:1 | monoclinic | P21/n | a 5.661 b 11.754 c 19.173 β 91.56° | [9] | ||||
Fumaric acid; urea (1:2) | 1:2 | monoclinic | P21/c | a 5.540 b 8.227 c 12.426 β 97.22° | [11] | ||||
D-Tartaric | 1:1 | orthorhombic | P212121 | a 17.229 b 9.824 c 5.056 Z=4 | 1.63 | transparent 255 to 1370 nm; SHG 3×KDP | [12] | ||
DL-Tartaric | 1:1 | monoclinic | P21 | a 7.6973 b 23.3310 c 4.8727 β 100.82° | NLO; transparent from 240 to 1950 nm | [13] | |||
Gluatric acid bis urea | 2:1 | monoclinic | C2/c | a 11.954 b 10.932 c 9.078 β 97.86° Z=4 | [14] | ||||
Itaconic acid | 1:1 | monoclinic | P21/c | a 12.71 b 5.2695 c 13.833β 104.78° | [15] | ||||
2-bromotetradecane urea | hexagonal | P6122 | a=8.2582 c=10.9937 | 298K | [16] | ||||
2-bromotetradecane urea | orthorhombic | C2221 | 207K | [16] | |||||
2-bromotetradecane urea | monoclinic | P21 | a 16.338(1)Å b 10.9665(8)Å c 16.338(1)Å, α 90° β 60.00° | [16] | |||||
4-amino benzoic acid; urea (2:1) | (C7H7NO2)2(CH4N2O) | 1:2 | orthorhombic | Pnab | a=7.4159 b=11.870 c=18.750 | [17] | |||
salicylic acid; urea (1:1) | 1:1 | monoclinic | C2/c | a=22.206 b=5.108 c=17.177 β=106.18 Z=8° | 1.407 | [18] | |||
5-nitro salicylic acid; urea (2:1) | (C7H5NO5)2(CH4N2O) | 1:2 | triclinic | P1 | a=6.9889 b=12.1968 c=12.3622 α=60.923° β=81.169° γ=76.938° | [17] | |||
3,5-dinitro salicylic acid; urea (1:1) | (C7H4N2O7)(CH4N2O) | 1:1 | monoclinic | P21/c | a=4.942 b=22.337 c=10.389 β=100.92° | [17] | |||
o-phthalic acid; urea (1:1) | 1:1 | triclinic | P1 | a=7.422 b=7.662 c=10.088 α=85.95° β=82.01° γ=65.14° | [17] | ||||
urea : 1,4-dioxane (1 : 1) | C4H8O2•C3H6O | 1:1 | monoclinic | P2/c | a=6.7949 b=4.5234 c=12.2711 β=95.701° Z=2 | [1] | |||
urea : morpholine (1 : 1) | C4H8ON•C3H6O | 1:1 | orthorhombic | Pbcm | a=4.5847 b=19.131 c=8.9047 Z=4 | [1] | |||
3,5-dimethylpyridine bis(urea) | (CH3)2C5H3N•2C3H6O | 2:1 | orthorhombic | Abm2 | a=21.737 b=7.2102 c=15.590 Z=8 | 2443.4 | 1.236 | at 173K | [19] |
3,5-dimethylpyridine bis(urea) | (CH3)2C5H3N•2C3H6O | 2:1 | monoclinic | Cc | a=8.5829 b=21.4843 c=7.2050 β=114.405° Z=4 | 1209.87 | 1.248 | at 100K | [19] |
2,6-dimethylpyridine urea | (CH3)2C5H3N•C3H6O | 1:1 | triclinic | P1 | a=7.4126 b=7.6720 c=8.1731 α=88.391° β=83.564° γ=80.059° Z=2 | 454.92 | 1.221 | at 100K | [19] |
urea 2,6-dimethylpyridine | (CH3)2C5H3N•C3H6O | 1:1 | monoclinic | C2/c | a=1.426 b=11.1168 c=7.4318 β=101.23° Z=4 | 925.9 | 1.200 | at 200K | [19] |
2,6-dimethylpyridine bis(urea) | (CH3)2C5H3N•2C3H6O | 2:1 | orthorhombic | Pnma | a=8.0772 b=7.2986 c=20.4169 Z=4 | 1203.64 | 1.254 | at 100K | [19] |
2,6-dimethylpyridine bis(urea) | (CH3)2C5H3N•2C3H6O | 2:1 | monoclinic | C2/c | a=11.160 b=11.5421 c=10.910 β=116.12° | [17] | |||
2-picoline; urea (1:1) | C6H7N·CH4N2O | 1:1 | orthorhombic | Pbca | a = 7.471 b = 14.916 c = 15.338 Z = 8 | 1709.2 | [20] | ||
Urea pyrazine-2,3-dicarboxylic acid | 1:1 | monoclinic | P21/n | a=7.725 b=10.2530 c=12.612 β=97.997° | [17] | ||||
bipyridine urea | triclinic | P1 | a=7.200 b=8.297 c=9.835 α=75.849° β=70.744° γ =73.045° | [21] | |||||
bipyridine urea | triclinic | P1 | a=7.2862 b=8.3747 c=9.8647 α=76.061° β=72.789° γ=74.121° | [21] | |||||
1,10-Phenanthroline urea | 1:1 | monoclinic | C2/c | a=14.342 b=12.002 c=7.3724 β 116.743° | [21] | ||||
2,9-Dimethyl-1,10-phenanthroline urea | 1:1 | orthorhombic | Cmcm | a=11.370 b=17.351 c=7.3593 | [21] | ||||
sodium chloride; urea; water (1:1:1) | NaCl·CH4N2O·H2O | 1:1 | triclinic | a = 6.44 Å, b = 5.245Å, c = 17.312 Å, and a=90°, β=90.15°, γ=90° | 588.76 | SHG 1.53 × KDP, birefringence 0.084@1064 nm UV edge 209 nm | [22] [23] | ||
Bis(2-3-isopropyl-7-oxocyclohepta-1,3,5-trien-1-olato)bis[(3-isopropyl-7-oxocyclohepta-1,3,5-trien-1-olato)copper(II)]-urea-acetone (1/6/2) | [Cu2(C10H11O2)4]·6CH4N2O·2C3H6O | 5:1 | monoclinic | P21/c | a 17.0125 b 11.0470 c 17.2731 β 110.385° Z=2 | 3042.95 | 1.371 | green | [24] |
aqua(N-salicylidene-rac-alaninato- O,N,O')copper(II)-urea (1/1) | 1:1 | triclinic | P1 | a = 7.637, b = 8.509 c = 10.716 α = 93.10° β = 97.97° γ= 106.37° Z= 2, | 658.5 | blue | [25] | ||
Aqua[9-(1,8-diazafluoren-9-ylidene)amino-1,8-diazafluorenato]hydroxo(urea)zinc(II) urea solvate | [Zn(C22H12N5)(OH)(CH4N2O)(H2O)]•C4N2O | 1:1 | monoclinic | P21/c | a 7.8637 b 16.0133 c 17.9513 β 101.358° Z=4 | 2216.2 | 1.687 | purple | [26] |
Pentakis(carbamide)dioxoneptunium(V) nitrate | [NpO2{OC(NH2)2}5](NO3) | monoclinic | P21 | a = 11.142, b = 7.6379 c = 11.143 β = 108.9° Z = 2 | 897.1 | [27] | |||
Bis[(isothiocyanato)tetraureadioxoneptunium(V)] urea | {NpO2(NCS)[OC(NH2)2]4}2 · OC(NH2)2 | tetragonal | P43212 | a=7.851 c=56.84 Z=4 | 3504 | 2.265 | light green | [28] |
In chemistry, water(s) of crystallization or water(s) of hydration are water molecules that are present inside crystals. Water is often incorporated in the formation of crystals from aqueous solutions. In some contexts, water of crystallization is the total mass of water in a substance at a given temperature and is mostly present in a definite (stoichiometric) ratio. Classically, "water of crystallization" refers to water that is found in the crystalline framework of a metal complex or a salt, which is not directly bonded to the metal cation.
Electron crystallography is a subset of methods in electron diffraction focusing upon detailed determination of the positions of atoms in solids using a transmission electron microscope (TEM). It can involve the use of high-resolution transmission electron microscopy images, electron diffraction patterns including convergent-beam electron diffraction or combinations of these. It has been successful in determining some bulk structures, and also surface structures. Two related methods are low-energy electron diffraction which has solved the structure of many surfaces, and reflection high-energy electron diffraction which is used to monitor surfaces often during growth.
Telluric acid, or more accurately orthotelluric acid, is a chemical compound with the formula Te(OH)6, often written as H6TeO6. It is a white crystalline solid made up of octahedral Te(OH)6 molecules which persist in aqueous solution. In the solid state, there are two forms, rhombohedral and monoclinic, and both contain octahedral Te(OH)6 molecules, containing one hexavalent tellurium (Te) atom in the +6 oxidation state, attached to six hydroxyl (–OH) groups, thus, it can be called tellurium(VI) hydroxide. Telluric acid is a weak acid which is dibasic, forming tellurate salts with strong bases and hydrogen tellurate salts with weaker bases or upon hydrolysis of tellurates in water. It is used as tellurium-source in the synthesis of oxidation catalysts.
Copper(I) iodide is an inorganic compound with the chemical formula CuI. It is also known as cuprous iodide. It is useful in a variety of applications ranging from organic synthesis to cloud seeding.
Uranyl chloride refers to inorganic compounds with the formula UO2Cl2(H2O)n where n = 0, 1, or 3. These are yellow-colored salts.
Urea phosphate is a 1:1 combination of urea and phosphoric acid that is used as a fertilizer. It has an NPK formula of 17-44-0, and is soluble in water, producing a strongly acidic solution.
Tin(II) sulfate (SnSO4) is a chemical compound. It is a white solid that can absorb enough moisture from the air to become fully dissolved, forming an aqueous solution; this property is known as deliquescence. It can be prepared by a displacement reaction between metallic tin and copper(II) sulfate:
In organic chemistry, thioureas are members of a family of organosulfur compounds with the formula S=C(NR2)2 and structure R2N−C(=S)−NR2. The parent member of this class of compounds is thiourea. Substituted thioureas are found in several commercial chemicals.
Acta Crystallographica is a series of peer-reviewed scientific journals, with articles centred on crystallography, published by the International Union of Crystallography (IUCr). Originally established in 1948 as a single journal called Acta Crystallographica, there are now six independent Acta Crystallographica titles:
Copper salicylate describes a range of compounds containing copper(II) and salicylate. Many compounds are known. They are generally blue. Simple species include:
Hydrogenoxalate or hydrogen oxalate(IUPAC name: 2-Hydroxy-2-oxoacetate) is an anion with chemical formula HC2O−4 or HO−C(=O)−CO−2, derived from oxalic acid by the loss of a single proton; or, alternatively, from the oxalate anion C2O2−4 by addition of a proton. The name is also used for any salt containing this anion. Especially in older literature, hydrogenoxalates may also be referred to as bioxalates, acid oxalates, or monobasic oxalates. Hydrogenoxalate is amphoteric, in that it can react both as an acid or a base.
Thiourea dioxide or thiox is an organosulfur compound that is used in the textile industry. It functions as a reducing agent. It is a white solid, and exhibits tautomerism.
Uranium triiodide is an inorganic compound with the chemical formula UI3. It is a black solid that is soluble in water.
Arthur William Pryor was an Australian physicist known for his contributions to neutron diffraction and infrared laser isotope separation. Pryor authored and co-authored a number of papers in the field of crystallography and he also co-authored, with B. T. M. Willis, the book Thermal Vibrations in Crystallography.
Monofluorophosphate is an anion with the formula PO3F2−, which is a phosphate group with one oxygen atom substituted with a fluoride atom. The charge of the ion is −2. The ion resembles sulfate in size, shape and charge, and can thus form compounds with the same structure as sulfates. These include Tutton's salts and langbeinites. The most well-known compound of monofluorophosphate is sodium monofluorophosphate, commonly used in toothpaste.
The Disordered Structure Refinement program (DSR), written by Daniel Kratzert, is designed to simplify the modeling of molecular disorder in crystal structures using SHELXL by George M. Sheldrick. It has a database of approximately 120 standard solvent molecules and molecular moieties. These can be inserted into the crystal structure with little effort, while at the same time chemically meaningful binding and angular restraints are set. DSR was developed because the previous description of disorder in crystal structures with SHELXL was very lengthy and error-prone. Instead of editing large text files manually and defining restraints manually, this process is automated with DSR.
This is a timeline of crystallography.
Uranyl oxalate (UO2C2O4) is a pale yellow powdered uranyl salt. It is often encountered in industrial nuclear processes at both the front and back-end of the nuclear fuel cycle. Due to its hygroscopicity, uranyl oxalate rarely exists in the dehydrated state and is usually instead found in the trihydrate form (UO2C2O4·3H2O) at room temperature. At room temperature, the powder exhibits a monoclinic crystal structure in the P21/c space group.
Arsenide bromides or bromide arsenides are compounds containing anions composed of bromide (Br−) and arsenide (As3−). They can be considered as mixed anion compounds. They are in the category of pnictidehalides. Related compounds include the arsenide chlorides, arsenide iodides, phosphide bromides, and antimonide bromides.
Alexander Frank Wells, or A. F. Wells, was a British chemist and crystallographer. He is known for his work on structural inorganic chemistry, which includes the description and classification of structural motifs, such as the polyhedral coordination environments, in crystals obtained from X-ray crystallography. His work is summarized in a classic reference book, Structural inorganic chemistry, first appeared in 1945 and has since gone through five editions. In addition, his work on crystal structures in terms of nets have been important and inspirational for the field of metal-organic frameworks and related materials.
{{cite journal}}
: CS1 maint: multiple names: authors list (link){{cite journal}}
: CS1 maint: DOI inactive as of November 2024 (link)